Artal Group S.A. Foghorn Therapeutics Inc. Transaction History
Artal Group S.A.
- $1.58 Billion
- Q2 2024
A detailed history of Artal Group S.A. transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Artal Group S.A. holds 720,720 shares of FHTX stock, worth $5.43 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
720,720
Previous 720,720
-0.0%
Holding current value
$5.43 Million
Previous $4.84 Million
14.31%
% of portfolio
0.26%
Previous 0.26%
Shares
2 transactions
Others Institutions Holding FHTX
# of Institutions
72Shares Held
32.8MCall Options Held
6KPut Options Held
1.8K-
Flagship Pioneering Inc. Cambridge, MA12.7MShares$95.4 Million8.71% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$39.9 Million0.93% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.52MShares$19 Million0.3% of portfolio
-
Raymond James & Associates St Petersburg, FL2.34MShares$17.6 Million0.01% of portfolio
-
Euclidean Capital LLC New York, NY1.57MShares$11.9 Million1.14% of portfolio
About Foghorn Therapeutics Inc.
- Ticker FHTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,637,400
- Market Cap $314M
- Description
- Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...